1. Home
  2. CPSS vs PLX Comparison

CPSS vs PLX Comparison

Compare CPSS & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$9.38

Market Cap

191.4M

Sector

Finance

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$1.82

Market Cap

204.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
PLX
Founded
1991
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.4M
204.9M
IPO Year
1992
1998

Fundamental Metrics

Financial Performance
Metric
CPSS
PLX
Price
$9.38
$1.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
23.1K
529.2K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.80
0.07
Revenue
$196,531,000.00
$61,840,000.00
Revenue This Year
$139.62
$14.29
Revenue Next Year
$10.58
$16.65
P/E Ratio
$11.50
$25.92
Revenue Growth
6.67
35.41
52 Week Low
$6.67
$1.32
52 Week High
$12.73
$3.10

Technical Indicators

Market Signals
Indicator
CPSS
PLX
Relative Strength Index (RSI) 66.09 44.81
Support Level $8.39 $1.68
Resistance Level $8.74 $1.78
Average True Range (ATR) 0.25 0.09
MACD 0.09 0.02
Stochastic Oscillator 80.69 78.57

Price Performance

Historical Comparison
CPSS
PLX

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

Share on Social Networks: